Peptides naturally presented by MHC class I molecules.
暂无分享,去创建一个
H. Rammensee | O. Rötzschke | K. Falk | O Rötzschke | K Falk | H G Rammensee | Hans-Georg Rammensee | H. Rammensee
[1] M. Bednarek,et al. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2. , 1991, Journal of immunology.
[2] M. Bevan,et al. Single-residue changes in class I major histocompatibility complex molecules stimulate responses to self peptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Claverie,et al. Working principles in the immune system implied by the "peptidic self" model. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[4] H. Rammensee,et al. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast , 1991, The Journal of experimental medicine.
[5] O. Rötzschke,et al. Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway. , 1991, Immunology today.
[6] R. Zinkernagel,et al. Nuclear myxovirus-resistance protein Mx is a minor histocompatibility antigen. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[7] H. Rammensee,et al. Identification of classical minor histocompatibility antigen as cell-derived peptide , 1990, Nature.
[8] V. Nussenzweig,et al. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria , 1989, Nature.
[9] J. Rodgers,et al. Specialized functions of MHC class I molecules. I. An N-formyl peptide receptor is required for construction of the class I antigen Mta , 1990, The Journal of experimental medicine.
[10] R. Zinkernagel,et al. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.
[11] H. Rammensee,et al. Isolation of human minor histocompatibility peptides. , 1992, International immunology.
[12] D. Anderson,et al. T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP , 1989, The Journal of experimental medicine.
[13] D. R. Madden,et al. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation , 1991, Nature.
[14] N. Huskisson,et al. Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule , 1992, Nature.
[15] H. Rammensee,et al. Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. , 1990, Science.
[16] S. Beck,et al. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters , 1990, Nature.
[17] P. Chomez,et al. Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide , 1990, The Journal of experimental medicine.
[18] M. A. Saper,et al. Specificity pockets for the side chains of peptide antigens in HLA-Aw68 , 1990, Nature.
[19] H. Rammensee,et al. Limit of T cell tolerance to self proteins by peptide presentation. , 1990, Science.
[20] T. Boon,et al. Structure of the gene of tum− transplantation antigen P91A: The mutated exon encodes a peptide recognized with Ld by cytolytic T cells , 1989, Cell.
[21] P. Weber,et al. Competitor analogs for defined T cell antigens: Peptides incorporating a putative binding motif and polyproline or polyglycine spacers , 1990, Cell.
[22] D. Wiley,et al. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.
[23] J. Whitton,et al. Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes , 1988, The Journal of experimental medicine.
[24] J. Yewdell,et al. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes , 1992, The Journal of experimental medicine.
[25] M. A. Saper,et al. Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.
[26] Timothy E. Elliott,et al. The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules , 1991, European journal of immunology.
[27] D. R. Madden,et al. Identification of self peptides bound to purified HLA-B27 , 1991, Nature.
[28] Hans-Georg Rammensee,et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells , 1990, Nature.
[29] L. Sherman,et al. Alloreactive T cells discriminate among a diverse set of endogenous peptides. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[30] H. Rammensee,et al. Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant. , 1992, International immunology.
[31] H. Rammensee,et al. Evidence from in vitro studies that tolerance to self antigens is MHC-restricted , 1984, Nature.
[32] B. Jordan,et al. H—2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide , 1986, Nature.
[33] J. Cerottini,et al. Synthetic peptides as antigens and competitors in recognition by H-2- restricted cytolytic T cells specific for HLA , 1988, The Journal of experimental medicine.
[34] P. Romero,et al. H-2Kd-restricted antigenic peptides share a simple binding motif , 1991, The Journal of experimental medicine.
[35] R. Webster,et al. Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin. , 1984, Journal of immunology.
[36] L. Sherman,et al. Peptide-dependent recognition of H–2Kb by alloreactive cytotoxic T lymphocytes , 1989, Nature.
[37] J. Monaco,et al. MHC class II region encoding proteins related to the muKidrug resistance family of transmembrane transporters , 1990, Nature.
[38] O. Werdelin. Determinant Protection. A Hypothesis for the Activity of Immune Response Genes in the Processing and Presentation of Antigens by Macrophages , 1986, Scandinavian journal of immunology.
[39] J. Strominger,et al. Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[40] H. Ploegh,et al. Different types of allospecific CTL clones identified by their ability to recognize peptide loading‐defective target cells , 1991, European journal of immunology.
[41] H. Rammensee,et al. Peptide motifs of closely related HLA class I molecules encompass substantial differences , 1992, European journal of immunology.
[42] R. Demars,et al. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway , 1990, Nature.
[43] D. Nixon,et al. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides , 1988, Nature.
[44] P. Lauzurica,et al. Structural identity between HLA-A2 antigens differentially recognized by alloreactive cytotoxic T lymphocytes. , 1991, Journal of immunology.
[45] T Spies,et al. Allelic variants of the human putative peptide transporter involved in antigen processing. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[46] R. Zinkernagel,et al. Major histocompatibility complex – dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease , 1989, European journal of immunology.
[47] R. Jaenisch,et al. Endogenous retroviruses lead to the expression of a histocompatibility antigen detectable by skin graft rejection. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[48] F. Lemonnier,et al. β2-Microglobulin restriction of antigen presentation , 1990, Nature.
[49] U. Koszinowski,et al. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein , 1991, Cell.
[50] P. A. Peterson,et al. Emerging principles for the recognition of peptide antigens by MHC class I molecules. , 1992, Science.
[51] S. Nathenson,et al. The structure of the antigen-binding groove of major histocompatibility complex class I molecules determines specific selection of self-peptides. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[52] P. A. Peterson,et al. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. , 1994, Science.
[53] J. Frelinger,et al. Evidence of widespread binding of HLA class I molecules to peptides , 1990, The Journal of experimental medicine.
[54] Günter J. Hämmerling,et al. Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex , 1991, Nature.
[55] R. Moots,et al. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA‐A2 in its recognition by cytotoxic T lymphocytes , 1992, European journal of immunology.
[56] H. Rammensee,et al. Restricted recognition of β2-microglobulin by cytotoxic T lymphocytes , 1986, Nature.
[57] A. Singer,et al. Role of the H-2 complex in the induction of T cell tolerance to self minor histocompatibility antigens , 1983, The Journal of experimental medicine.
[58] A. McMichael,et al. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides , 1986, Cell.
[59] E. Goulmy,et al. Y-antigen killing by T cells of women is restricted by HLA , 1977, Nature.
[60] R. Zinkernagel,et al. Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide , 1991, European journal of immunology.
[61] T. Boon,et al. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice , 1991, The Journal of experimental medicine.
[62] A. Vitiello,et al. The role of beta 2-microglobulin in peptide binding by class I molecules. , 1990, Science.
[63] H. von Boehmer,et al. Self-nonself discrimination by T cells. , 1990, Science.
[64] J. Rothbard,et al. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes , 1989, Nature.
[65] Robert DeMars,et al. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter , 1991, Nature.
[66] H. Eisen,et al. A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein , 1992, Cell.
[67] R. Linsk,et al. Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecule. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[68] A. Rudensky,et al. Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.
[69] C. Mackay,et al. Qa-1 restricted recognition of foreign antigen by a γδ T-cell hybridoma , 1989, Nature.
[70] H. Rammensee,et al. Self tolerance of natural MHC class I ligands. , 1993, International reviews of immunology.
[71] P. Chomez,et al. Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[72] P. Chomez,et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 1991, Science.
[73] S. Nathenson,et al. Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule , 1990, Nature.
[74] W. Kast,et al. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[75] R. Graff,et al. Recognition of the beta-2 microglobulin-B molecule by a CTL clone. , 1987, Journal of immunology.
[76] J. Monaco,et al. Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene , 1991, Nature.
[77] R. Henderson,et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.
[78] J. Levy,et al. Physical association between MHC class I molecules and immunogenic peptides , 1989, Nature.
[79] R. Germain. Immunology: The ins and outs of antigen processing and presentations , 1986, Nature.
[80] J. Monaco,et al. Transport protein genes in the murine MHC: possible implications for antigen processing. , 1990, Science.
[81] G. Brownlee,et al. Characterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin , 1991, Journal of virology.
[82] T. Braciale,et al. Nonconventional (TL-encoded) major histocompatibility complex molecules present processed viral antigen to cytotoxic T lymphocytes , 1991, The Journal of experimental medicine.
[83] M. Luscher,et al. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis , 1991, Nature.
[84] M. Cohn,et al. Is the establishing of tolerance to self obligatorily MHC restricted? , 1992, Immunology letters.
[85] S. Beck,et al. Second proteasome-related gene in the human MHC class II region , 1991, Nature.
[86] H. Yonekawa,et al. Maternally transmitted histocompatibility antigen of mice: A hydrophobic peptide of a mitochondrially encoded protein , 1990, Cell.
[87] Maria L. Wei,et al. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides , 1992, Nature.
[88] P. Chomez,et al. Genes coding for T-cell-defined tum transplantation antigens: point mutations, antigenic peptides, and subgenic expression. , 1989, Cold Spring Harbor symposia on quantitative biology.
[89] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[90] H. Rammensee,et al. Uneven tissue distribution of minor histocompatibility proteins versus peptides is caused by MHC expression , 1991, Cell.
[91] M. Bevan. Interaction antigens detected by cytotoxic T cells with the major histocompatibility complex as modifier , 1975, Nature.
[92] H. Grey,et al. Characterization of a naturally processed MHC class II-restricted T-cell determinant of hen egg lysozyme , 1989, Nature.
[93] A. Townsend,et al. Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter , 1991, Nature.